Annual Retained Earnings
-$252.63 M
-$37.88 M-17.64%
31 December 2023
Summary:
Seelos Therapeutics annual retained earnings is currently -$252.63 million, with the most recent change of -$37.88 million (-17.64%) on 31 December 2023. During the last 3 years, it has fallen by -$177.46 million (-236.11%). SEEL annual retained earnings is now -2987.81% below its all-time high of -$8.18 million, reached on 31 December 1997.SEEL Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$253.58 M
+$1.71 M+0.67%
30 June 2024
Summary:
Seelos Therapeutics quarterly retained earnings is currently -$253.58 million, with the most recent change of +$1.71 million (+0.67%) on 30 June 2024. Over the past year, it has dropped by -$6.41 million (-2.59%). SEEL quarterly retained earnings is now -1419.43% below its all-time high of -$16.69 million, reached on 31 March 2000.SEEL Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.6% | -2.6% |
| 3 y3 years | -236.1% | -122.5% |
| 5 y5 years | +22.3% | -458.5% |
SEEL Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -236.1% | at low | -122.5% | +1.6% |
| 5 y | 5 years | -350.6% | +22.3% | -458.5% | +1.6% |
| alltime | all time | -2987.8% | +22.3% | -1419.4% | +22.0% |
Seelos Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -$253.58 M(-0.7%) |
| Mar 2024 | - | -$255.29 M(+1.1%) |
| Dec 2023 | -$252.63 M(+17.6%) | -$252.63 M(+2.2%) |
| Sept 2023 | - | -$247.17 M(-4.1%) |
| June 2023 | - | -$257.67 M(+12.9%) |
| Mar 2023 | - | -$228.18 M(+6.3%) |
| Dec 2022 | -$214.74 M(+52.1%) | -$214.74 M(+9.5%) |
| Sept 2022 | - | -$196.09 M(+11.1%) |
| June 2022 | - | -$176.48 M(+13.7%) |
| Mar 2022 | - | -$155.21 M(+9.9%) |
| Dec 2021 | -$141.21 M(+87.9%) | -$141.21 M(+23.9%) |
| Sept 2021 | - | -$113.95 M(+10.5%) |
| June 2021 | - | -$103.14 M(+9.4%) |
| Mar 2021 | - | -$94.28 M(+25.4%) |
| Dec 2020 | -$75.16 M(+34.1%) | -$75.16 M(+9.4%) |
| Sept 2020 | - | -$68.71 M(+6.3%) |
| June 2020 | - | -$64.62 M(+6.1%) |
| Mar 2020 | - | -$60.89 M(+8.6%) |
| Dec 2019 | -$56.06 M(-82.8%) | -$56.06 M(+23.5%) |
| Sept 2019 | - | -$45.40 M(+7.6%) |
| June 2019 | - | -$42.18 M(+4.6%) |
| Mar 2019 | - | -$40.32 M(-87.6%) |
| Dec 2018 | -$325.23 M(+2.9%) | -$325.23 M(+0.6%) |
| Sept 2018 | - | -$323.37 M(+0.9%) |
| June 2018 | - | -$320.54 M(+0.7%) |
| Mar 2018 | - | -$318.26 M(+0.7%) |
| Dec 2017 | -$315.99 M(-0.1%) | -$315.99 M(+0.8%) |
| Sept 2017 | - | -$313.54 M(+1.2%) |
| June 2017 | - | -$309.71 M(+0.5%) |
| Mar 2017 | - | -$308.24 M(-2.6%) |
| Dec 2016 | -$316.31 M(+2.4%) | -$316.31 M(+0.1%) |
| Sept 2016 | - | -$316.01 M(+0.4%) |
| June 2016 | - | -$314.72 M(+1.1%) |
| Mar 2016 | - | -$311.38 M(+0.8%) |
| Dec 2015 | -$308.88 M(+6.6%) | -$308.88 M(+0.8%) |
| Sept 2015 | - | -$306.54 M(+1.7%) |
| June 2015 | - | -$301.51 M(+1.8%) |
| Mar 2015 | - | -$296.26 M(+2.2%) |
| Dec 2014 | -$289.85 M(+8.1%) | -$289.85 M(+6.3%) |
| Sept 2014 | - | -$272.56 M(+1.2%) |
| June 2014 | - | -$269.45 M(-0.7%) |
| Mar 2014 | - | -$271.33 M(+1.2%) |
| Dec 2013 | -$268.07 M(+6.7%) | -$268.07 M(+0.5%) |
| Sept 2013 | - | -$266.72 M(+1.1%) |
| June 2013 | - | -$263.74 M(+1.5%) |
| Mar 2013 | - | -$259.80 M(+3.5%) |
| Dec 2012 | -$251.13 M(+14.5%) | -$251.13 M(+8.5%) |
| Sept 2012 | - | -$231.49 M(+1.1%) |
| June 2012 | - | -$229.00 M(+2.2%) |
| Mar 2012 | - | -$224.07 M(+2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | -$219.36 M(+9.0%) | -$219.36 M(+2.2%) |
| Sept 2011 | - | -$214.67 M(+1.0%) |
| June 2011 | - | -$212.45 M(+3.8%) |
| Mar 2011 | - | -$204.65 M(+1.7%) |
| Dec 2010 | -$201.24 M(+17.2%) | -$201.24 M(+7.1%) |
| Sept 2010 | - | -$187.85 M(+1.4%) |
| June 2010 | - | -$185.25 M(+2.4%) |
| Mar 2010 | - | -$180.97 M(+5.4%) |
| Dec 2009 | -$171.73 M(+22.9%) | -$171.73 M(+21.3%) |
| Sept 2009 | - | -$141.62 M(+0.8%) |
| June 2009 | - | -$140.43 M(+1.0%) |
| Mar 2009 | - | -$139.00 M(-0.5%) |
| Dec 2008 | -$139.69 M(+3.8%) | -$139.69 M(-0.8%) |
| Sept 2008 | - | -$140.83 M(+2.2%) |
| June 2008 | - | -$137.79 M(+1.2%) |
| Mar 2008 | - | -$136.16 M(+1.2%) |
| Dec 2007 | -$134.52 M(+7.0%) | -$134.52 M(+2.0%) |
| Sept 2007 | - | -$131.82 M(+1.6%) |
| June 2007 | - | -$129.76 M(+1.6%) |
| Mar 2007 | - | -$127.77 M(+1.6%) |
| Dec 2006 | -$125.73 M(+6.8%) | -$125.73 M(+1.7%) |
| Sept 2006 | - | -$123.60 M(+1.6%) |
| June 2006 | - | -$121.62 M(+0.8%) |
| Mar 2006 | - | -$120.59 M(+2.5%) |
| Dec 2005 | -$117.69 M(+15.1%) | -$117.69 M(+2.8%) |
| Sept 2005 | - | -$114.44 M(+2.9%) |
| June 2005 | - | -$111.25 M(+4.1%) |
| Mar 2005 | - | -$106.87 M(+4.5%) |
| Dec 2004 | -$102.25 M(+20.0%) | -$102.25 M(+4.4%) |
| Sept 2004 | - | -$97.97 M(+5.1%) |
| June 2004 | - | -$93.25 M(+4.5%) |
| Mar 2004 | - | -$89.20 M(+4.7%) |
| Dec 2003 | -$85.22 M(+25.3%) | -$85.22 M(+8.4%) |
| Sept 2003 | - | -$78.59 M(+4.2%) |
| June 2003 | - | -$75.41 M(+5.6%) |
| Mar 2003 | - | -$71.44 M(+5.1%) |
| Dec 2002 | -$67.99 M(+68.5%) | -$67.99 M(+13.8%) |
| Sept 2002 | - | -$59.74 M(+13.0%) |
| June 2002 | - | -$52.87 M(+15.1%) |
| Mar 2002 | - | -$45.93 M(+13.8%) |
| Dec 2001 | -$40.35 M(+66.9%) | -$40.35 M(+17.2%) |
| Sept 2001 | - | -$34.43 M(+11.2%) |
| June 2001 | - | -$30.97 M(+13.1%) |
| Mar 2001 | - | -$27.38 M(+13.3%) |
| Dec 2000 | -$24.17 M(+55.9%) | -$24.17 M(+15.1%) |
| Sept 2000 | - | -$21.00 M(+9.6%) |
| June 2000 | - | -$19.16 M(+14.8%) |
| Mar 2000 | - | -$16.69 M |
| Dec 1999 | -$15.50 M(+89.5%) | - |
| Dec 1997 | -$8.18 M | - |
FAQ
- What is Seelos Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Seelos Therapeutics?
- What is Seelos Therapeutics annual retained earnings year-on-year change?
- What is Seelos Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly retained earnings year-on-year change?
What is Seelos Therapeutics annual retained earnings?
The current annual retained earnings of SEEL is -$252.63 M
What is the all time high annual retained earnings for Seelos Therapeutics?
Seelos Therapeutics all-time high annual retained earnings is -$8.18 M
What is Seelos Therapeutics annual retained earnings year-on-year change?
Over the past year, SEEL annual retained earnings has changed by -$37.88 M (-17.64%)
What is Seelos Therapeutics quarterly retained earnings?
The current quarterly retained earnings of SEEL is -$253.58 M
What is the all time high quarterly retained earnings for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly retained earnings is -$16.69 M
What is Seelos Therapeutics quarterly retained earnings year-on-year change?
Over the past year, SEEL quarterly retained earnings has changed by -$6.41 M (-2.59%)